David Shaw’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$790K Sell
138,084
-4,839
-3% -$27.8K ﹤0.01% 3913
2026
Q1
$898K Buy
142,923
+30,056
+27% +$279K ﹤0.01% 3515
2025
Q4
$1.38M Sell
112,867
-208,184
-65% -$3.4M ﹤0.01% 3326
2025
Q3
$6.58M Sell
321,051
-91,845
-22% -$1.46M ﹤0.01% 1986
2025
Q2
$5.57M Buy
412,896
+62,977
+18% +$689K ﹤0.01% 1944
2025
Q1
$3.03M Buy
349,919
+54,202
+18% +$331K ﹤0.01% 2294
2024
Q4
$1.44M Buy
295,717
+32,062
+12% +$179K ﹤0.01% 2979
2024
Q3
$2.04M Sell
263,655
-44,679
-14% -$397K ﹤0.01% 2704
2024
Q2
$3.08M Sell
308,334
-40,558
-12% -$446K ﹤0.01% 2244
2024
Q1
$4.24M Sell
348,892
-113,615
-25% -$1.65M ﹤0.01% 2010
2023
Q4
$6.62M Sell
462,507
-137,886
-23% -$1.32M 0.01% 1679
2023
Q3
$4.67M Buy
600,393
+64,414
+12% +$701K ﹤0.01% 1867
2023
Q2
$7.66M Buy
535,979
+64,747
+14% +$922K 0.01% 1554
2023
Q1
$6.89M Buy
471,232
+286,250
+155% +$4.79M 0.01% 1675
2022
Q4
$3.11M Buy
184,982
+100,553
+119% +$1.74M ﹤0.01% 2555
2022
Q3
$1.25M Buy
+84,429
New +$1.67M ﹤0.01% 3420
2021
Q2
Sell
-8,838
Closed -$431K 4940
2021
Q1
$431K Sell
8,838
-10,385
-54% -$501K ﹤0.01% 3569
2020
Q4
$599K Buy
+19,223
New +$471K ﹤0.01% 3305

Other funds holding OPRX

David Shaw's OPRX Position: Q2 2026 in Review

David Shaw reduced its OptimizeRx (OPRX) stake by 3.4% in Q2 2026, selling an estimated $27.8K and leaving 138,084 shares worth $790K. The position accounts for ﹤0.01% of the portfolio, ranked #3913.

David Shaw first reported a position in OPRX in Q4 2020 and has held it in 18 quarters since. The position peaked at $7.66M in Q2 2023. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • David Shaw held 138,084 shares of OptimizeRx worth $790K as of Q2 2026.
  • David Shaw sold 4,839 OptimizeRx shares in Q2 2026, an estimated $27.8K.
  • OptimizeRx made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3913 holding.
  • David Shaw first reported a position in OptimizeRx in Q4 2020 and has held it in 18 quarters since.
  • David Shaw's OptimizeRx position peaked at $7.66M in Q2 2023.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.